Two Stony Brook Medicine Department of Surgery faculty have recently been recognized for their dedication to medical education and contributions to the field of medicine. Doctors Huseyin Isildak (Head and Neck Surgery, Otolaryngology) and Allison McLarty (Cardiothoracic Surgery, Thoracic Surgery) have been promoted to Professor of Surgery in the Renaissance School of Medicine.
Huseyin Isildak, MD, is Director of Otology/Neurotology and Director of Cochlear Implant Program in Stony Brook's Division of Otolaryngology–Head and Neck Surgery (ENT) and affiliated with Stony Brook's Skull Base Surgery Center. He is board certified in Otolaryngology, graduated from the Istanbul School of Medicine in Istanbul, Turkey and did his residency at the Department of Otolaryngology, Cerrahpasa Medical School, Istanbul University. Dr. Isildak joined Stony Brook after fellowships at Delaware Otologic Medicine and Surgery, Paparella Ear Neck and Head Institute, Minneapolis, Minnesota; and eight years as Director of Otology/Neurotology at Penn State Hershey Medical Center.
Dr. Isildak has published dozens of peer-reviewed manuscripts and multiple book chapters, presented multiple abstracts at national meetings, serves as a reviewer for many otology/neurotology/laryngology-related journals and has held editorial positions for publications including BioMed Central (BMC) Cancer, CSurgeries, Operative Techniques in Otolaryngology-Head and Neck Surgery/Elsevier and Operative Techniques in Otolaryngology. He has won multiple honors and awards including a proclamation from the Town of Brookhaven during the Town Hall Eid al Fitr Celebration that recognized the dedication of healthcare professionals, an Excellence in Teaching Golden Adam's Apple Reward from Stony Brook ENT, a Faculty Teaching and Mentorship Award from Penn State Health, an Exceptional Teaching Recognition from the Penn State Office for a Respectful Learning Environment and the Best Doctors® in America award for 2018 and 2020. He is also a member of several societies and organizations including the American Otological Society, the North American Skull Base Society, American Neurotology Society, the AOS/COSM 2024 Program Advisory Committee and the American Medical Association.
"This promotion is not just a testament to my personal growth and hard work, but also a reflection of the supportive and stimulating environment in our department," said Dr. Isildak. "It's an affirmation that we're on the right path, and I'm eager to contribute even more to our collective goals in my new role. Every achievement, including this promotion, is a result of the collective effort of our dedicated team. I see this as an opportunity to inspire and motivate others to continue their pursuit of professional and personal growth."
Allison McLarty, MD, is Chief of Surgery at Northport VA Medical Center, Director, ECMO Program; Director, Ventricular Assist Device Program; Head, Lung Cancer Program and is affiliated with Stony Brook's Aortic Center, Heart Failure Center, Heart Institute, Lung Cancer Evaluation Center and the Women's Heart Center. She is board certified in Thoracic Surgery and Surgery and did her residency at Columbia-Presbyterian Medical Center after graduating from Columbia University Medical School. Dr. McLarty joined Stony Brook Medicine after completing a Cardiothoracic Surgery fellowship at the Mayo Clinic in Rochester, Minnesota.
Dr. McLarty, a Fellow, American College of Surgeons (FACS), has been selected by Castle Connolly for their 2023 Top Doctors List for Thoracic & Cardiac Surgery. Her additional honors include selection for inclusion in Guide to America's Top Surgeons published by the Consumers' Research Council of America, Outstanding Teacher Award presented by Stony Brook's General Surgery residents, the Town of Brookhaven's Women's Recognition Award for Medicine and the Village Times Herald's 2002 "Woman of the Year in Health" award.
Focused on all forms of heart disease, chest disease and lung cancer (she is on the Lung Cancer Evaluation Center team), Dr. McLarty's special interest is in aortic surgery and the use of minimally invasive endovascular stenting for thoracic aortic aneurysms. As Director of the Ventricular Assist Device (VAD) Program, she promotes the use of leading-edge technology to treat severe heart failure, such as the permanent VAD device, which provides “destination therapy” (Stony Brook's VAD program was the first on Long Island to be certified nationally). She also is an expert in addressing the unique cardiac needs of women and is active in the Women’s Heart Program.
"It has been a privilege working with students, residents and faculty at Stony Brook Medicine in both the clinical and research arenas," said Dr. McLarty. "I came here 26 years ago fresh out of fellowship training from the Mayo Clinic. One might say I 'grew up' as an attending here and I’m appreciative of all I have learned from colleagues and been able to contribute to the University."
We congratulate Doctors Huseyin Isildak and Allison McLarty on their promotions, recognize their impressive accomplishments and thank them for their continued devotion to patient care and the education of future doctors.